Category - Company spotlights

Bluebee’s coherent data strategy set to unify Illumina’s data analytics products

This month’s attention-grabbing headlines in the field of genomics, genetics, and precision medicine can undoubtedly be attributed to the acquisition of Bluebee by Illumina. I spoke with Hans Cobben, CEO of Bluebee and...read more

BC Platforms Aims to Advance Clinical Decision-Making by Enhancing Clinical Data with Genomics Information

This month’s “Company Spotlight” provides a closer look at the Finnish-Swiss company BC Platforms, a genomic data management and analysis solutions provider, working to revolutionize drug development and to enable...read more

Nebion Provides Curated Omics Data Combined with Innovative Visualizations for Target Discovery, Indication Finding, and Drug Safety Assessment

For this month’s “Company Spotlight” blog series we are reviewing Nebion, a Swiss bioinformatics company, in an interview with Philip Zimmermann, Co-founder and CEO of Nebion. Nebion is a 30-person company headquartered...read more

Sentieon Solves Complex Mathematical Problems – Applied to DNA Sequence Secondary Data Analysis – by Enhancing them With Extreme Accuracy and Efficiency

Category - Company spotlights

Nebion Provides Curated Omics Data Combined with Innovative Visualizations for Target Discovery, Indication Finding, and Drug Safety Assessment

Othram Aims to Overcome DNA Sequencing Challenges to Solve Forensic Crime Cases

Immunotherapy and the Basis of Neoantigen Biology: Part I Neoantigens

Blueprint Genetics Aims to Automate and Improve Clinical Interpretation Processes with Software That Will Change the Industry

Nebula Genomics’ Goal Is To Make The Value of Genome Sequencing a Reality

Genohm Aims to Hit the Sweet Spot With a Customizable SLIMS + ELN Solution for Lab Information Management

enlightenbio Customer Spotlight: Lab7 Systems Product Definition, Strategy, and Positioning

enlightenbio Customer Spotlight: Cypher Genomics Clinical Content Curation

Follow Me

Most popular

Quest Diagnostics Granted CDC Contract to Sequence COVID-19 Gene Variants to Aid Public Health Response to COVID-19

Leading Biopharmaceutical Companies Select Invitae to Develop Standardized Panel to Detect Molecular Residual Disease (MRD) in Patients with Acute Myeloid Leukemia (AML)

Pacific Biosciences and Invitae to Develop Ultra-High-Throughput Clinical Whole Genome Sequencing Platform

Personal Genome Diagnostics and QIAGEN Collaborate to Offer Integrated Genomic Testing and Interpretation Support

The Promise and Hope of RNA-based vaccines for COVID-19

Delfi Diagnostics Announces $100 Million Series A Financing to Develop a New Class of Early Detection Liquid Biopsy for Multiple Cancers

NuProbe Closes $42M Fundraising

Helix® Laboratory Platform Granted the First and Only FDA Authorization for a Whole Exome Sequencing Platform

QIAGEN Announces Global Distribution Agreement for the COSMIC Database from the Wellcome Sanger Institute

Pharmacogenetic and Genealogy Pioneers Merge for Historic Partnership

Illumina and Helix Collaborate to Assess Prevalence of New SARS-CoV-2 UK Variant (B.1.1.7) in the US and Develop National Surveillance Infrastructure

Most discussed

Genohm Aims to Hit the Sweet Spot With a Customizable SLIMS + ELN Solution for Lab Information Management

Just Released – Our New Clinical NGS Process Report

Genomenon’s Automated Genomic Search Engine Mastermind Illuminates Current Trends in Genomic Literature – A Look at the Top Cited Variants Across the Scientific Literature

The JP Morgan Healthcare Conference from Afar

Immunotherapy and the Basis of Neoantigen Biology: Part I Neoantigens

Nebula Genomics’ Goal Is To Make The Value of Genome Sequencing a Reality

The Life of a Genetic Counselor: Providing Patient Education, Navigating Insurance, and Challenges in Choosing Tests

Review of Emerging 2018 Genomic Variants – a Genomenon Research Report

PMWC 2016 Silicon Valley: Scalable Clinical Data Interpretation The Biggest Bottleneck